Hillhouse Capital is set to supply more than $830m for JD.com's pharmaceutical and medical services spinoff, which raised about $1bn last year.

Collaboration partner Gilead Sciences provided $20m as the cancer therapy researcher extended its overall equity funding to $165m.

Portland State University spinout DesignMedix has shut down after its phase 1 trial for an antimalaria treatment caused side effects.

The immuno-oncology company – co-founded by Juno Therapeutics, a spinout of several institutions – is reportedly seeking $250m to $300m in a Hong Kong offering.

PNNL's biomolecule analysis equipment spinout Mobilion Systems will use the funding for recruitment aimed at driving its product roadmap.

WuXi AppTec and Juno Therapeutics' immuno-oncology joint venture is reportedly seeking $250m to $300m in a Hong Kong offering.

Agilent returned for a round that pushed the medical device developer's overall funding past the $50m mark and which will go to commercialising its Slim technology.

Johnson & Johnson Innovation – JJDC participated in a round that boosted the total raised by the hair loss, migraine and acid reflux treatment provider to $70m.

The medical booking management app was reportedly valued at $310m following the round, which was led by AIA and which included Tencent and Alphabet.

Fosun Capital is among the investors that have backed $14.4m in series A and A-plus rounds for the eyecare equipment maker which will fund research and development efforts.